Viewing Study NCT03470805


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:12 AM
Study NCT ID: NCT03470805
Status: COMPLETED
Last Update Posted: 2022-09-23
First Post: 2018-02-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
Sponsor: Grupo Español de Investigación en Cáncer de Ovario
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module